17 August 2017
News and Views
Links and Services
July's issue of the Alimentary Pharmacology & Therapeutics reviews the epidemiology of the hepatobiliary manifestations in patients with inflammatory bowel disease.
Extraintestinal manifestations are frequent in inflammatory bowel diseases (IBD).
Email this page to a colleague
Whole-genome sequencing in primary care
GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors